{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:48:32Z","timestamp":1786736912655,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["20-015-00164"],"award-info":[{"award-number":["20-015-00164"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ejps.2021.105792","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T01:07:03Z","timestamp":1615252023000},"page":"105792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Searching for new anxiolytic agents among derivatives of 11-dialkylaminoethyl-2,3,4,5-tetrahydrodiazepino[1,2-a]benzimidazole"],"prefix":"10.1016","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2005-6621","authenticated-orcid":false,"given":"Dmitriy V.","family":"Maltsev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Spasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8980-6016","authenticated-orcid":false,"given":"Dmitriy S.","family":"Yakovlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel M.","family":"Vassiliev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria O.","family":"Skripka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail V.","family":"Miroshnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira T.","family":"Sultanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey N.","family":"Kochetkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila N.","family":"Divaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana A.","family":"Kuzmenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9182-6101","authenticated-orcid":false,"given":"Anatolii S.","family":"Morkovnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2021.105792_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2017.02.047","article-title":"Characterization of 6-methoxyflavanone as a novel anxiolytic agent: A behavioral and pharmacokinetic approach","volume":"801","author":"Akbar","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105792_bib0002","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11094-013-0862-0","article-title":"Synthesis and pharmacological activity of amides of 2, 3-dihydroimidazo-and 2, 3, 4, 10-tetrahydropyrimido [1, 2-a] benzimidazolyln-acetic acids","volume":"46","author":"Anisimova","year":"2013","journal-title":"Pharmaceut. Chem J."},{"key":"10.1016\/j.ejps.2021.105792_bib0003","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bbr.2018.10.028","article-title":"Dopamine transporter (DAT) knockdown in the nucleus accumbens improves anxiety-and depression-related behaviors in adult mice","volume":"359","author":"Bahi","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejps.2021.105792_bib0004","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(16)31790-1","article-title":"GBD 2015: from big data to meaningful change","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2021.105792_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/13651501.2012.667114","article-title":"Guidelines for the pharmacological treatment of anxiety disorders, obsessive\u2013compulsive disorder and posttraumatic stress disorder in primary care","volume":"16","author":"Bandelow","year":"2012","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.ejps.2021.105792_bib0006","doi-asserted-by":"crossref","first-page":"e52323","DOI":"10.1371\/journal.pone.0052323","article-title":"A unified model of the GABAA receptor comprising agonist and benzodiazepine binding sites","volume":"8","author":"Bergmann","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2021.105792_bib0007","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.biopha.2018.04.077","article-title":"Tert-butyl 4-((1-phenyl-1H-pyrazol-4-yl) methyl) piperazine-1-carboxylate (LQFM104)\u2013New piperazine derivative with antianxiety and antidepressant-like effects: Putative role of serotonergic system","volume":"103","author":"da Silva","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejps.2021.105792_bib0008","doi-asserted-by":"crossref","first-page":"e2695","DOI":"10.1002\/hup.2695","article-title":"Exploring characteristics associated with first benzodiazepine prescription in patients with affective disorders and related diagnoses","volume":"34","author":"De Carlo","year":"2019","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ejps.2021.105792_bib0009","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3389\/fphar.2018.01225","article-title":"Imepitoin shows benzodiazepine-like effects in models of anxiety","volume":"9","author":"Engel","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105792_bib0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneumeth.2017.01.009","article-title":"Assessment of gait and sensorimotor deficits in the D1CT-7 mouse model of Tourette syndrome","volume":"292","author":"Fowler","year":"2017","journal-title":"J. Neurosci. Methods."},{"key":"10.1016\/j.ejps.2021.105792_bib0011","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1021\/acs.jmedchem.6b01858","article-title":"Discovery and preclinical characterization of 3-((4-(4-chlorophenyl)-7-fluoroquinoline-3-yl) sulfonyl) benzonitrile, a novel non-acetylenic metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator for psychiatric indications","volume":"60","author":"Galambos","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2021.105792_bib0012","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/164_2018_188","article-title":"NOP ligands for the treatment of anxiety and mood disorders","volume":"254","author":"Gavioli","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105792_bib0013","doi-asserted-by":"crossref","first-page":"9691","DOI":"10.1021\/acs.jmedchem.7b01151","article-title":"Identification of a new pyrazolo [1, 5-a] quinazoline ligand highly affine to \u03b3-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity","volume":"60","author":"Guerrini","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2021.105792_bib0014","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/acer.14074","article-title":"Affective behavior in withdrawal seizure-prone and withdrawal seizure-resistant mice during long-term alcohol abstinence","volume":"43","author":"Hartmann","year":"2019","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.ejps.2021.105792_bib0015","doi-asserted-by":"crossref","first-page":"e01376","DOI":"10.1016\/j.heliyon.2019.e01376","article-title":"Chalcone derivatives: synthesis, in vitro and in vivo evaluation of their anti-anxiety, anti-depression and analgesic effects","volume":"5","author":"Higgs","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.ejps.2021.105792_bib0016","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuint.2016.10.010","article-title":"Corrigendum to \"In vitro, molecular modeling and behavioral studies of'3-{[4-(5-methoxy-1H-indol-3-yl)-1, 2, 3, 6-tetrahydropyridin-1-yl] methyl}-1, 2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic","volume":"100","author":"Kaczor","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejps.2021.105792_bib0017","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jphs.2014.11.008","article-title":"The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats","volume":"127","author":"Kasahara","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2021.105792_bib0018","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/fcp.12443","article-title":"Anxiolytic-like effects of the new arylpiperazine derivatives containing isonicotinic and picolinic nuclei: behavioral and biochemical studies","volume":"33","author":"K\u0119dzierska","year":"2019","journal-title":"Fundam Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105792_bib0019","doi-asserted-by":"crossref","unstructured":"Larbie, C., Owusu Nyarkoh, C., Owusu Adjei, C., 2019. Phytochemical and safety evaluation of hydroethanolic leaf extract of Tecoma stans (L.) Juss. ex Kunth. Evid. Based Complement. Altern. Med. 2019. https:\/\/doi.org\/10.1155\/2019\/7417624.","DOI":"10.1155\/2019\/7417624"},{"key":"10.1016\/j.ejps.2021.105792_bib0020","unstructured":"LigandScout Inte:Ligand GmbH. http:\/\/www.inteligand.com\/ligandscout\/."},{"key":"10.1016\/j.ejps.2021.105792_bib0021","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pbb.2018.04.007","article-title":"FGIN-1-27, an agonist at translocator protein 18 kDa (TSPO), produces anti-anxiety and anti-panic effects in non-mammalian models","volume":"171","author":"Lima-Maximino","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejps.2021.105792_bib0022","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/01616412.2019.1611204","article-title":"Activation and blockade of dorsal hippocampal Serotonin6 receptors regulate anxiety-like behaviors in a unilateral 6-hydroxydopamine rat model of Parkinson's disease","volume":"41","author":"Liu","year":"2019","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ejps.2021.105792_bib0023","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1523\/JNEUROSCI.2226-18.2019","article-title":"NPY2 receptors reduce tonic action potential-independent GABAB currents in the basolateral amygdala","volume":"39","author":"Mackay","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2021.105792_bib0024","first-page":"10","article-title":"Effect of chronic administration and withdrawal of caffeine on motor function, cognitive functions, anxiety, and the social behavior of BLC57 mice","volume":"13","author":"Mahdi","year":"2019","journal-title":"Int. J. Health Sci."},{"key":"10.1016\/j.ejps.2021.105792_bib0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejphar.2019.03.039","article-title":"Multiple actions of fenamates and other nonsteroidal anti-inflammatory drugs on GABAA receptors","volume":"853","author":"Mansikkam\u00e4ki","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105792_bib0026","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/molecules22050800","article-title":"The hypnotic, anxiolytic, and antinociceptive profile of a novel \u00b5-opioid agonist","volume":"22","author":"Montes","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2021.105792_bib0027","unstructured":"MarvinSketch, ChemAxon Kft. http:\/\/www.chemaxon.com\/products\/marvin\/marvinsketch\/."},{"key":"10.1016\/j.ejps.2021.105792_bib0028","unstructured":"MOPAC, Stewart Computational Chemistry. http:\/\/openmopac.net."},{"key":"10.1016\/j.ejps.2021.105792_bib0029","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1007\/s00213-015-4069-9","article-title":"\u03b12-containing GABA(A) receptors: a requirement for midazolam-escalated aggression and social approach in mice","volume":"232","author":"Newman","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejps.2021.105792_bib0030","doi-asserted-by":"crossref","unstructured":"Olkkola, K.T., Ahonen, J., 2008. Midazolam and other benzodiazepines, in: Sch\u00fcttler, J., Schwilden, H. (Eds.), Modern Anesthetics. Handbook of Experimental Pharmacology, vol 182. Springer, Berlin, Heidelberg, pp. 335\u2013360. https:\/\/doi.org\/10.1007\/978-3-540-74806-9_16.","DOI":"10.1007\/978-3-540-74806-9_16"},{"key":"10.1016\/j.ejps.2021.105792_bib0031","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1042\/BCJ20170648","article-title":"TSPO mutations in rats and a human polymorphism impair the rate of steroid synthesis","volume":"474","author":"Owen","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejps.2021.105792_bib0032","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00210-016-1229-3","article-title":"ADN-1184, a monoaminergic ligand with 5-HT6\/7 receptor antagonist action, exhibits activity in animal models of anxiety","volume":"389","author":"Partyka","year":"2016","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105792_bib0033","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s42358-018-0022-z","article-title":"Effects of a health education program on cytokines and cortisol levels in fibromyalgia patients: a randomized controlled trial","volume":"58","author":"Pernambuco","year":"2018","journal-title":"Adv. Rheumatol."},{"issue":"sup1","key":"10.1016\/j.ejps.2021.105792_bib0034","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1080\/15622975.2018.1468030","article-title":"Anxiolytics targeting GABAA receptors: Insights on etifoxine","volume":"19","author":"Poisbeau","year":"2018","journal-title":"World J. Biol. Psychiatry."},{"key":"10.1016\/j.ejps.2021.105792_bib0035","unstructured":"RCSB PDB, Protein Data Bank. https:\/\/www.rcsb.org\/."},{"key":"10.1016\/j.ejps.2021.105792_bib0036","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/wps.20611","article-title":"Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders","volume":"18","author":"Reed","year":"2019","journal-title":"World Psychiatry"},{"key":"10.1016\/j.ejps.2021.105792_bib0037","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jpsychires.2016.10.007","article-title":"4-phenylselenyl-7-chloroquinoline, a novel multitarget compound with anxiolytic activity: Contribution of the glutamatergic system","volume":"84","author":"Reis","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejps.2021.105792_bib0038","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuropharm.2014.07.018","article-title":"The benzodiazepine midazolam acts on the expression of the defensive behavior, but not on the processing of aversive information, produced by exposure to the elevated plus maze and electrical stimulations applied to the inferior colliculus of rats","volume":"88","author":"Saito","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejps.2021.105792_bib0039","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12992-020-00589-w","article-title":"Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis","volume":"16","author":"Salari","year":"2020","journal-title":"Global Health"},{"key":"10.1016\/j.ejps.2021.105792_bib0040","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuropharm.2016.10.019","article-title":"Novel, highly potent and in vivo active inhibitor of GABA transporter subtype 1 with anticonvulsant, anxiolytic, antidepressant and antinociceptive properties","volume":"113","author":"Sa\u0142at","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejps.2021.105792_bib0041","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbr.2016.01.048","article-title":"Evaluation of the antidepressant- and anxiolytic-like activity of \u03b1-spinasterol, a plant derivative with TRPV1 antagonistic effects, in mice","volume":"303","author":"Soca\u0142a","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejps.2021.105792_bib0042","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/0004867418818362","article-title":"Will the RANZCP clinical practice guidelines for the treatment of anxiety disorders assist in making adequate treatment decisions for panic disorder?","volume":"53","author":"Starcevic","year":"2019","journal-title":"Aust. N Z J Psychiatry."},{"key":"10.1016\/j.ejps.2021.105792_bib0043","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/FBP.0000000000000327","article-title":"Agonist E-6837 and antagonist SB-271046 of 5-HT6 receptors both reverse the depressive-like effect induced in mice by subchronic ketamine administration","volume":"28","author":"Su\u00e1rez-Santiago","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105792_bib0044","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0018-18.2019","article-title":"The role of glutamatergic and dopaminergic neurons in the periaqueductal gray\/dorsal raphe: Separating analgesia and anxiety","volume":"6","author":"Taylor","year":"2019","journal-title":"eNeuro"},{"key":"10.1016\/j.ejps.2021.105792_bib0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejps.2021.105792_bib0046","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1134\/S1990750819030107","article-title":"Neural network modeling of multitarget RAGE inhibitory activity","volume":"13","author":"Vassiliev","year":"2019","journal-title":"Biochemistry (Moscow) Suppl. Series B: Biomed. Chem."},{"key":"10.1016\/j.ejps.2021.105792_bib0047","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF00765242","article-title":"Synthesis and sedative properties of dl-tetrahydropalmatine","volume":"17","author":"Vinogradova","year":"1983","journal-title":"Pharmaceut. Chem. J."},{"key":"10.1016\/j.ejps.2021.105792_bib0048","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12017-016-8425-7","article-title":"Antidepressant-like and anxiolytic-like effects of ZBD-2, a novel ligand for the translocator protein (18 kDa)","volume":"19","author":"Wang","year":"2017","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.ejps.2021.105792_bib0049","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s00213-016-4292-z","article-title":"The anxiolytic-and antidepressant-like effects of ATPM-ET, a novel \u03ba agonist and \u03bc partial agonist, in mice","volume":"233","author":"Wang","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejps.2021.105792_bib0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-0035-1558003","article-title":"Enhancing neurosteroid synthesis\u2013relationship to the pharmacology of translocator protein (18 kDa)(TSPO) ligands and benzodiazepines","volume":"48","author":"Wolf","year":"2015","journal-title":"Pharmacopsychiatry"},{"issue":"S","key":"10.1016\/j.ejps.2021.105792_bib0051","first-page":"58","article-title":"Optimization of MTT assay for evaluation of cytotoxicity of new chemical compounds on MCF-7 cell line [in Russian]","volume":"1","author":"Yakovlev","year":"2020","journal-title":"Volgograd Scientif. Med. J."},{"key":"10.1016\/j.ejps.2021.105792_bib0052","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11094-017-1578-3","article-title":"The search for pharmacologically active compounds among the 2-Dialkylaminobenzimidazoles","volume":"51","author":"Zhukovskaya","year":"2017","journal-title":"Pharmaceut. Chem. J."},{"key":"10.1016\/j.ejps.2021.105792_bib0053","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jad.2018.10.082","article-title":"Diagnostic consequences of a new category of anxious depression and a reduced duration requirement for anxiety symptoms in the ICD-11 PHC","volume":"245","author":"Ziebold","year":"2019","journal-title":"J. Affect. Disord."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721000944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721000944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:57:44Z","timestamp":1760529464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721000944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":53,"alternative-id":["S0928098721000944"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105792","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Searching for new anxiolytic agents among derivatives of 11-dialkylaminoethyl-2,3,4,5-tetrahydrodiazepino[1,2-a]benzimidazole","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105792"}}